Supplementary Material for: The first case of Eruptive pyogenic granuloma following Covid-19 vaccination

Introduction: Pyogenic granuloma presents clinically as a rapidly growing, friable, red papule of skin or mucosa, commonly measuring less than 10 mm with frequent bleeding due to ulceration. Angioproliferative diseases including pyogenic granuloma and cherry angioma have been reported during Covid-19 infection or following Covid-19 vaccination. Case presentation: Here, we report a 52-year-old-female patient who developed diffuse skin eruptions three weeks after the second dose of Covid-19 vaccination. Conclusion: per our knowledge, this is the first case of eruptive PG following Covid-19 vaccination. Oral propranolol and PDL laser therapy were administered after obtaining inconvenient results from electro-cautery, and there was a good response within 6 weeks of starting therapy, defined by the cessation of new lesion formation and a decrease in the size of large lesions.